Page last updated: 2024-09-05

emd 53998 and fluo-3

emd 53998 has been researched along with fluo-3 in 1 studies

Compound Research Comparison

Studies (emd 53998)	Trials (emd 53998)	Recent Studies (post-2010) (emd 53998)	Studies (fluo-3)	Trials (fluo-3)	Recent Studies (post-2010) (fluo-3)
112	0	9	759	1	108

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chiesi, M; Depersin, H; Grüninger, S; Hasenfuss, G; Herzig, JW; Holubarsch, C; Kubalek, R; Leutert, T; Pieske, B; Pioch, K; Wenk, P	1

Other Studies

1 other study(ies) available for emd 53998 and fluo-3

Article	Year
Ca2+ sensitization in idiopathic dilated human myocardium. Differential in vitro effects of (+)-(5-methyl-6-phenyl)-1,3,5,6-tetrahydro-3,6-methano-1,5-benzodiazoci ne-2,4-dione, a novel purely Ca2+sensitizing agent, and (+)-5-(1-(3,4-dimethoxybenzoyl)-1,2 Arzneimittel-Forschung, 1996, Volume: 46, Issue:6 Topics: Aniline Compounds; Azocines; Calcium; Cardiomyopathy, Dilated; Cardiotonic Agents; Electric Stimulation; Humans; In Vitro Techniques; Myocardial Contraction; Myocardium; Phosphodiesterase Inhibitors; Quinolines; Stimulation, Chemical; Thiadiazines; Xanthenes	1996

Article

Year

Ca2+ sensitization in idiopathic dilated human myocardium. Differential in vitro effects of (+)-(5-methyl-6-phenyl)-1,3,5,6-tetrahydro-3,6-methano-1,5-benzodiazoci ne-2,4-dione, a novel purely Ca2+sensitizing agent, and (+)-5-(1-(3,4-dimethoxybenzoyl)-1,2

Arzneimittel-Forschung, 1996, Volume: 46, Issue:6

Topics: Aniline Compounds; Azocines; Calcium; Cardiomyopathy, Dilated; Cardiotonic Agents; Electric Stimulation; Humans; In Vitro Techniques; Myocardial Contraction; Myocardium; Phosphodiesterase Inhibitors; Quinolines; Stimulation, Chemical; Thiadiazines; Xanthenes

1996